Photos: 

Some evaluation reports are public and can be downloaded from this website, while others are restricted to MSF users and can only be accessed via Tukul. This limitation is mainly due to the sensitive nature of the operational contexts and the resulting content. However, there are internal discussions about making all evaluation reports publicly searchable. If you are an MSF association member, reports are made available on various associate platforms such as www.insideOCB.com.

Topic

Country/Region

In 2015, MSF operations and medical directors recognised antibiotic resistance (ABR) as a priority and called for the elaboration of an intersectional roadmap to tackle ABR in MSF projects. The MSF ABR Task Force was consolidated in 2017 with joint medical and operational governance.

These case study reports were produced at the request of MSF-OCBA, under the management of the Vienna Evaluation Unit. They were prepared independently by the respective authors.
09/09/2019

Since 2014, MSF has been implementing health programs for key populations (KP) mainly along a major transport corridor running through Mozambique and Malawi.

This evaluation was conceived to evaluate each program individually, and then to look at all programs comparatively in order to discern which interventions were most effective. Furthermore, the intention was to consider the sum of the MSF experience in these programs to infer an optimal model of care that responds best to the health needs.

 

This evaluation was conducted by Richard Bedell & Victoria Bungay under the management of the Stockholm Evaluation Unit of MSF. Finalized in December 2018.
19/03/2019

The objective of this lessons learnt exercise was to assess the advantages and disadvantages of the UNITAID grant governance and management model for project achievements in terms of medical (and related) outcomes, strategic decisions, the potential for collaboration between multiple MSF entities and to leverage the learnings for replication in future projects. The exercise showed that the project directly delivered a new, more effective, simpler and much cheaper treatment to patients across seven countries.

This publication was produced at the request of MSF OCG, under the management of the Vienna Evaluation Unit. It was prepared independently by Hugues Juillerat, Sharon McClenaghan and Glenn O’Neil of TRAASS International.
15/01/2019

L’objectif de cette évaluation est d’analyser la pertinence de l’intervention de MSF-OCG en RCA en apportant des réponses à deux questions spécifiques:

This publication was produced at the request of MSF OCG, under the management of the Vienna Evaluation Unit. It was prepared independently by Antoine GAUGE & Vladimir NAJMAN.
08/05/2018

Optimizing HIV, TB and NCD treatment in five sub-saharan countries.

This publication was produced at the request of MSF OCB, under the management of the Stockholm Evaluation Unit. It was prepared independently by Catherine Lalonde and Joost van der Meer.
12/02/2018

This document describes the project Lessons identified at the end of the market entry planning phase for MSF in Finland. It summarises the successes and challenges encountered during the project, lists the learning themes arising from these successes and challenges, and includes a set of lessons derived from an analysis of these learning points. The Annex contains a proposed (brief) framework with criteria and pre-requisites for a successful Market Entry Plan in MSF based on this experience. NOTE: This is not an evaluation and therefore there is no ambition for independent judgement.

This Retrospect was facilitated by the Stockholm Evaluation Unit on behalf of the Project Team. The report has been prepared by Timothy McCann.
30/10/2017

Integration of HIV/TB services is one of the priorities for the MSF movement since 2010 and in particular for OCBA that started hand over of the so-called vertical programs in the same year. This process has finished for the total of 16 vertical HIV programs of MSF-OCBA started since 2005. Integration aims to provide access to HIV/TB care to all populations in need in locations where MSF has implemented regular projects, regardless of the HIV prevalence in places such as CAR (started in 2008), South Sudan (2011) and Niger (2014).

This publication was produced at the request of MSF OCBA, under the management of the Athens Evaluation Unit. It was prepared independently by Geraldine Brun and Heinz Henghuber (TL) and managed by the Athens Evaluation Referent Dimitra Kageropoulos.
10/11/2016

This report is a review of advocacy within the MSF movement from 2010-2015. Commissioned by the core ExCom, the aim of this review was to explore the effectiveness of MSF advocacy and produce recommendations to improve its approach, coordination and organization in support to operations within the movement. Two external evaluation consultants, Glenn O’Neil and Liesbeth Schockaert, conducted the review with the support of Nirupama Sarma who carried out a complementary review of the Access Campaign (AC).

This publication was produced at the request of MSF International, under the management of the Vienna Evaluation Unit. It was prepared independently by Glenn O'Neil and Liesbeth Schockaert, with contributions from Nirupama Sarma.
14/09/2016

Full version and short version available. This evaluation of the viral load (VL) monitoring system was commissioned in order to more fully understand the experience and outcomes of the introduction and scale-up of VL in one district of Zimbabwe but also undertaken with a view to the national scale-up of VL monitoring, and the general issue of VL monitoring in sub-Saharan Africa in light of the UNAIDS 90-90-90 targets. The report details five clear recommendations to reach undetectable viral load.

This publication was produced at the request of MSF OCB, under the management of the Stockholm Evaluation Unit. It was prepared independently by Richard Bedell.
21/04/2016

MSF has received UNITAID grants since 2013. For several financial, operational and opportunistic reasons, the opportunity and adequacy of receiving funds from UNITAID was questioned by the MSF medical and operational directors. In October 2014 the MedOp platform took a decision not to seek any further UNITAID funding for a one-year period-ending in October 2015.

This evaluation was conducted by Nicole Henze on behalf of the Stockholm Evaluation Unit of MSF. Finalised in November 2015. This publication was produced at the request of MSF MedOp, under the management of the Stockholm Evaluation Unit. It was prepared independently by Nicole Henze.
30/12/2015

Pages